A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome

Gastroenterology and Hepatology

Volumn 6, Issue 4, 2010, Pages 233-236

  Azhar, Ashaur ^a   Niazi, Mumtaz A ^a   Tufail, Kashif ^a   Malek, Ashraf H ^a   Balasubramanian, Manjula ^a   Araya, Victor ^a  

^a EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CONSENSUS INTERFERON; DULOXETINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RIBAVIRIN; VIRUS RNA;

ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; ULTRASOUND;

EID: 77952517972     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ghany MG, Strader DB, Thomas DL, Seeff LB. AASLD practice guidelines: diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-1374.
2. Schiano TD, Te HS, Thomas RM, Hussain H, Bond K, Black M. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol. 2001;96:2984-2991. (Pubitemid 32959543)
3. Petersen-Benz C, Kasper HU, Dries V, Goeser T. Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2004;2:440-443. (Pubitemid 38561243)
4. Czaja AJ. Autoimmune hepatitis. In: Feldman M, Scharschmidt BF, Sleisenger MH, Fordtran JS, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia, Pennsylvania: WB Saunders Company; 1998:1265-1274.
5. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613-619.
6. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut. 1999;45:435-441. (Pubitemid 29400723)
7. Williams MJ, Lawson A, Neal KR, Ryder SD, Irving WL; Trent HCV Group. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat. 2009;16:325-331.
8. Pegasys (PegInterferon alfa-2a) [package insert]. Hoffman-La Roche, Lab, Inc.
9. Garcia-Buey L, Garcia-Monzon C, Rodriguez S, Borque MJ, García-Sánchez A, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology. 1995;108:1770-1777.
10. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology. 1992;102(4 pt 1):1406-1408.
11. Vento S, Di Perri G, Garofano T, Cosco L, Concia E, et al. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet. 1989;2:926. (Pubitemid 19245323)
12. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med. 1992;116:51-53.
13. Magy N, Cribier B, Schmitt C, Ellero B, Jaeck D, et al. Effects of corticosteroids on HCV infection. Int J Immunopharmacol. 1999;21:253-261. (Pubitemid 29241777)
14. Czaja AJ. Autoimmune hepatitis and viral infection. Gastroenterol Clin North Am. 1994;23:547-566.
15. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588-598.
16. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 1992;15:572-577.
17. Bellary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine. Ann Intern Med 1995;123:32-34.
18. Montano Loza AJ, Czaja AJ. Current therapy for autoimmune hepatitis. Nat Clin Pract Gastroenterol Hepatol. 2007;4:202-214.
19. Infergen (Interferon alfacon-1) [package insert]. Three Rivers Pharmaceuticals, LLC. Revised August 2009.